• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用镓-奥曲肽PET/CT、静脉采血和3T-MRI对肿瘤性骨软化症进行有效的定位

Effective localization in tumor-induced osteomalacia using Ga-DOTATOC-PET/CT, venous sampling and 3T-MRI.

作者信息

Kawai Shintaro, Ariyasu Hiroyuki, Furukawa Yasushi, Yamamoto Reika, Uraki Shinsuke, Takeshima Ken, Warigaya Kenji, Nakamoto Yuji, Akamizu Takashi

机构信息

The First Department of Medicine.

Department of Human Pathology, Wakayama Medical University, WakayamaJapan.

出版信息

Endocrinol Diabetes Metab Case Rep. 2017 Apr 19;2017. doi: 10.1530/EDM-17-0005. eCollection 2017.

DOI:10.1530/EDM-17-0005
PMID:28469928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5409940/
Abstract

SUMMARY

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by renal phosphate wasting leading to hypophosphatemia due to excessive actions of fibroblast growth factor 23 (FGF23) produced by the tumors. Although the best way of curing TIO is complete resection, it is usually difficult to detect the culprit tumors by general radiological modalities owing to the size and location of the tumors. We report a case of TIO in which the identification of the tumor by conventional imaging studies was difficult. Nonetheless, a diagnosis was made possible by effective use of multiple modalities. We initially suspected that the tumor existed in the right dorsal aspect of the scapula by Ga-DOTATOC positron emission tomography/computed tomography (Ga-DOTATOC-PET/CT) and supported the result by systemic venous sampling (SVS). The tumor could also be visualized by 3T-magnetic resonance imaging (MRI), although it was not detected by 1.5T-MRI, and eventually be resected completely. In cases of TIO, a stepwise approach of Ga-DOTATOC-PET/CT, SVS and 3T-MRI can be effective for confirmation of diagnosis.

LEARNING POINTS

TIO shows impaired bone metabolism due to excessive actions of FGF23 produced by the tumor. The causative tumors are seldom detected by physical examinations and conventional radiological modalities.In TIO cases, in which the localization of the culprit tumors is difficult, Ga-DOTATOC-PET/CT should be performed as a screening of localization and thereafter SVS should be conducted to support the result of the somatostatin receptor (SSTR) imaging leading to increased diagnosability.When the culprit tumors cannot be visualized by conventional imaging studies, using high-field MRI at 3T and comparing it to the opposite side are useful after the tumor site was determined.

摘要

摘要

肿瘤诱导的骨软化症(TIO)是一种罕见的副肿瘤综合征,其特征是肿瘤产生的成纤维细胞生长因子23(FGF23)作用过度导致肾脏磷酸盐流失,进而引起低磷血症。虽然治愈TIO的最佳方法是完全切除肿瘤,但由于肿瘤的大小和位置,通过常规放射学检查通常很难检测到罪魁祸首肿瘤。我们报告一例TIO病例,通过传统影像学检查难以识别肿瘤。尽管如此,通过有效使用多种检查方法得以确诊。我们最初通过镓标记的生长抑素受体拮抗剂(Ga-DOTATOC)正电子发射断层扫描/计算机断层扫描(Ga-DOTATOC-PET/CT)怀疑肿瘤存在于肩胛骨右背侧,并通过全身静脉采血(SVS)支持该结果。尽管1.5T磁共振成像(MRI)未检测到肿瘤,但该肿瘤也可通过3T磁共振成像(MRI)显示,最终被完全切除。在TIO病例中,采用Ga-DOTATOC-PET/CT、SVS和3T-MRI的逐步检查方法对确诊有效。

学习要点

TIO因肿瘤产生的FGF23作用过度而导致骨代谢受损。通过体格检查和传统放射学检查很少能检测到致病肿瘤。在难以确定罪魁祸首肿瘤位置的TIO病例中,应进行Ga-DOTATOC-PET/CT作为定位筛查,然后进行SVS以支持生长抑素受体(SSTR)成像结果,从而提高诊断率。当通过传统影像学检查无法显示罪魁祸首肿瘤时,在确定肿瘤部位后,使用3T高场MRI并与对侧进行比较是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9430/5409940/123457ae834b/edmcr-2017-170005-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9430/5409940/4eb1dbc1a1d4/edmcr-2017-170005-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9430/5409940/d6f1c21c21d7/edmcr-2017-170005-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9430/5409940/745c81008906/edmcr-2017-170005-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9430/5409940/123457ae834b/edmcr-2017-170005-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9430/5409940/4eb1dbc1a1d4/edmcr-2017-170005-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9430/5409940/d6f1c21c21d7/edmcr-2017-170005-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9430/5409940/745c81008906/edmcr-2017-170005-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9430/5409940/123457ae834b/edmcr-2017-170005-g004.jpg

相似文献

1
Effective localization in tumor-induced osteomalacia using Ga-DOTATOC-PET/CT, venous sampling and 3T-MRI.使用镓-奥曲肽PET/CT、静脉采血和3T-MRI对肿瘤性骨软化症进行有效的定位
Endocrinol Diabetes Metab Case Rep. 2017 Apr 19;2017. doi: 10.1530/EDM-17-0005. eCollection 2017.
2
Diagnostic performance of Ga-DOTATOC PET/CT in tumor-induced osteomalacia.镓[68Ga]DOTATOC PET/CT 在肿瘤性骨软化症中的诊断性能。
Ann Nucl Med. 2021 Mar;35(3):397-405. doi: 10.1007/s12149-021-01575-x. Epub 2021 Feb 13.
3
Usefulness of Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia.镓- DOTATOC PET/CT 对定位致骨软化症的元凶肿瘤的作用。
Sci Rep. 2021 Jan 19;11(1):1819. doi: 10.1038/s41598-021-81491-2.
4
A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.一例罕见的沿腱鞘多发磷尿性间叶肿瘤致骨软化症病例。
BMC Musculoskelet Disord. 2017 Feb 13;18(1):79. doi: 10.1186/s12891-017-1446-z.
5
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在致佝偻病罪犯肿瘤靶向成像中的比较。
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.
6
68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.68Ga DOTA-TATE PET/CT能够在肿瘤诱导的骨软化症患者中定位肿瘤,而这些患者的111In-奥曲肽SPECT/CT检查结果为阴性。
Bone. 2014 Jul;64:222-7. doi: 10.1016/j.bone.2014.04.016. Epub 2014 Apr 24.
7
Diagnostic performance and impact on patient management of Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.镓- DOTATOC PET/CT 检测骨软化症相关肿瘤的诊断性能及其对患者管理的影响。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1710-1720. doi: 10.1007/s00259-018-3971-x. Epub 2018 Mar 12.
8
Tumor-Induced Osteomalacia Localized and Excised After Pregnancy.妊娠后定位并切除的肿瘤性骨软化症
AACE Clin Case Rep. 2021 Jun 18;7(6):363-366. doi: 10.1016/j.aace.2021.06.008. eCollection 2021 Nov-Dec.
9
Tumor-induced osteomalacia.肿瘤诱导的骨软化症。
Bone Rep. 2017 Sep 20;7:90-97. doi: 10.1016/j.bonr.2017.09.002. eCollection 2017 Dec.
10
Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia.镓-68 DOTATOC正电子发射断层显像/X线计算机体层成像(PET/CT)引导下活检及冷冻消融联合活检标本放射自显影术治疗肿瘤性骨软化症
Cardiovasc Intervent Radiol. 2016 Sep;39(9):1352-7. doi: 10.1007/s00270-016-1350-1. Epub 2016 May 5.

引用本文的文献

1
Tumor-Induced Osteomalacia Localized by Systemic Venous Sampling and Ga-DOTATOC Positron Emission Tomography.通过全身静脉采样和镓- DOTATOC正电子发射断层扫描定位肿瘤诱导的骨软化症
JCEM Case Rep. 2025 Jan 24;3(2):luaf012. doi: 10.1210/jcemcr/luaf012. eCollection 2025 Feb.
2
[Clinical features, diagnostics and treatment of FGF23 secreting tumors: series of 40 clinical cases].[成纤维细胞生长因子23分泌性肿瘤的临床特征、诊断与治疗:40例临床病例系列]
Probl Endokrinol (Mosk). 2023 Nov 10;69(5):25-38. doi: 10.14341/probl13221.
3
A Case of Tumor-Induced Osteomalacia Detected by Venous Sampling.

本文引用的文献

1
Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.镓-多柔比星用于肿瘤性骨软化症的肿瘤定位
J Clin Endocrinol Metab. 2016 Oct;101(10):3575-3581. doi: 10.1210/jc.2016-2052. Epub 2016 Aug 17.
2
Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia.镓-68 DOTATOC正电子发射断层显像/X线计算机体层成像(PET/CT)引导下活检及冷冻消融联合活检标本放射自显影术治疗肿瘤性骨软化症
Cardiovasc Intervent Radiol. 2016 Sep;39(9):1352-7. doi: 10.1007/s00270-016-1350-1. Epub 2016 May 5.
3
Tumour-induced osteomalacia: a literature review and a case report.
一例通过静脉采血检测出的肿瘤诱导性骨软化症病例。
Int Med Case Rep J. 2023 Oct 10;16:659-665. doi: 10.2147/IMCRJ.S425599. eCollection 2023.
4
Atypical Fragility Fractures due to Bony or Soft Tissue Phosphaturic Mesenchymal Tumors: A Report of Two Cases.骨或软组织磷酸酶性间叶肿瘤所致非典型脆性骨折:2例报告
Case Rep Orthop. 2023 Apr 12;2023:5614065. doi: 10.1155/2023/5614065. eCollection 2023.
5
Phosphaturic mesenchymal tumor in right thigh: 2 cases report and literature review.右大腿磷酸尿性间叶肿瘤:2例报告并文献复习
Clin Pathol. 2022 Oct 21;15:2632010X221129588. doi: 10.1177/2632010X221129588. eCollection 2022 Jan-Dec.
6
Approach to Hypophosphatemic Rickets.低磷血症性佝偻病的处理方法。
J Clin Endocrinol Metab. 2022 Dec 17;108(1):209-220. doi: 10.1210/clinem/dgac488.
7
Tumor-induced osteomalacia characterized by "painful knee joint with difficulty in moving": a case report.肿瘤相关性骨软化症以“膝关节疼痛伴活动困难”为特征:病例报告。
BMC Endocr Disord. 2022 Jul 8;22(1):174. doi: 10.1186/s12902-022-01078-4.
8
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors.生长抑素受体(激动剂)PET示踪剂在神经内分泌肿瘤以外的临床应用
Diagnostics (Basel). 2022 Feb 18;12(2):528. doi: 10.3390/diagnostics12020528.
9
FGF-23 transmitted tumor - induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature.成纤维细胞生长因子-23介导肿瘤诱导的低磷性骨软化症:一名反复骨折年轻女性的罕见病例及文献复习
J Bone Oncol. 2022 Jan 29;33:100413. doi: 10.1016/j.jbo.2022.100413. eCollection 2022 Apr.
10
Malignant transformation of phosphaturic mesenchymal tumor: a case report and literature review.磷尿性间叶肿瘤的恶性转化:一例报告及文献复习
Clin Pediatr Endocrinol. 2020;29(2):69-75. doi: 10.1297/cpe.29.69. Epub 2020 Apr 16.
肿瘤诱导的骨软化症:文献综述与病例报告
World J Surg Oncol. 2016 Jan 8;14(1):4. doi: 10.1186/s12957-015-0763-7.
4
Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia.成纤维细胞生长因子 23 产生肿瘤患者的肿瘤性骨软化症的诊断方法。
Endocrinol Metab (Seoul). 2014 Jun;29(2):136-43. doi: 10.3803/EnM.2014.29.2.136.
5
Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).磷酸尿苷肿瘤显示生长抑素受体 2A(SSTR2A)阳性染色。
Hum Pathol. 2013 Dec;44(12):2711-8. doi: 10.1016/j.humpath.2013.07.016. Epub 2013 Sep 20.
6
Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy.经分次立体定向放疗成功治疗颅内肿瘤所致肿瘤性骨软化症。
J Clin Endocrinol Metab. 2013 Nov;98(11):4267-72. doi: 10.1210/jc.2013-2528. Epub 2013 Sep 6.
7
Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.成纤维细胞生长因子23的体静脉采样在识别肿瘤性骨软化症相关肿瘤中的临床应用
J Intern Med. 2010 Oct;268(4):390-4. doi: 10.1111/j.1365-2796.2010.02262.x.
8
Tumor-induced hypophosphatemic rickets in an adolescent boy--clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue.青少年男性肿瘤相关性低血磷性佝偻病——临床表现、诊断和生长板及肌肉组织的组织学表现。
J Clin Endocrinol Metab. 2010 Oct;95(10):4511-7. doi: 10.1210/jc.2010-0543. Epub 2010 Jul 21.
9
Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.通过磁共振成像和FGF23静脉采样联合程序诊断的肿瘤诱导的低磷性骨软化症
Intern Med. 2008;47(10):957-61. doi: 10.2169/internalmedicine.47.0745. Epub 2008 May 15.
10
Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23.
Intern Med. 2008;47(7):637-41. doi: 10.2169/internalmedicine.47.0761. Epub 2008 Apr 1.